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Abstract
Bacterial contact-dependent growth inhibition (CDI) is mediated by the CdiA/CdiB family of two-partner secretion proteins.
Each CdiA protein exhibits a distinct growth inhibition activity, which resides in the polymorphic C-terminal region (CdiA-
CT). CDI
+ cells also express unique CdiI immunity proteins that specifically block the activity of cognate CdiA-CT, thereby
protecting the cell from autoinhibition. Here we show that many CDI systems contain multiple cdiA gene fragments that
encode CdiA-CT sequences. These ‘‘orphan’’ cdiA-CT genes are almost always associated with downstream cdiI genes to
form cdiA-CT/cdiI modules. Comparative genome analyses suggest that cdiA-CT/cdiI modules are mobile and exchanged
between the CDI systems of different bacteria. In many instances, orphan cdiA-CT/cdiI modules are fused to full-length cdiA
genes in other bacterial species. Examination of cdiA-CT/cdiI modules from Escherichia coli EC93, E. coli EC869, and Dickeya
dadantii 3937 confirmed that these genes encode functional toxin/immunity pairs. Moreover, the orphan module from EC93
was functional in cell-mediated CDI when fused to the N-terminal portion of the EC93 CdiA protein. Bioinformatic analyses
revealed that the genetic organization of CDI systems shares features with rhs (rearrangement hotspot) loci. Rhs proteins
also contain polymorphic C-terminal regions (Rhs-CTs), some of which share significant sequence identity with CdiA-CTs. All
rhs genes are followed by small ORFs representing possible rhsI immunity genes, and several Rhs systems encode orphan
rhs-CT/rhsI modules. Analysis of rhs-CT/rhsI modules from D. dadantii 3937 demonstrated that Rhs-CTs have growth
inhibitory activity, which is specifically blocked by cognate RhsI immunity proteins. Together, these results suggest that Rhs
plays a role in intercellular competition and that orphan gene modules expand the diversity of toxic activities deployed by
both CDI and Rhs systems.
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Introduction
Many bacteria lead social lives in communities where they
cooperate and compete with members of their own species, as well
as those of other species [1]. One mechanism of bacterial
communication is quorum sensing, in which small signaling
molecules are released to coordinate group behavior when a
critical cell density has been attained [2]. Other modes of
communication based on direct cell-to-cell contact have recently
been identified in bacteria. Contact-dependent signaling helps to
coordinate cell aggregation and fruiting body formation in
Myxococcus xanthus [3], and is also exploited to inhibit the growth
of neighboring cells. Contact-dependent growth inhibition (CDI)
was first described in the Escherichia coli isolate EC93 [4], and has
subsequently been demonstrated in Dickeya dadantii 3937 [5]. CDI
is mediated by the CdiB-CdiA two-partner secretion system. CdiB
is a predicted outer membrane b-barrel protein that is required for
secretion and presentation of the CdiA exoprotein on the cell
surface [6,7]. Like other two-partner secretion exoproteins, CdiA
contains an N-terminal transport domain followed by a hemag-
glutinin repeat region that is predicted to adopt an extended
filamentous b-helical structure [7–9]. The CDI growth inhibitory
activity resides within the C-terminus of CdiA (CdiA-CT). The cdi
locus also encodes a small CdiI immunity protein immediately
downstream of cdiA. CdiI protects EC93 cells from CdiA-mediated
growth autoinhibition [5].
CDI systems are widespread amongst a-, b-, and c-proteobac-
teria [5]. CdiA exoproteins are related throughout most of their
length, which varies from 1,400 to 2,000 amino acid residues in
Neisseria and Moraxella species to over 5,600 residues for some
Dickeya and Pseudomonas strains [5]. However, the CdiA-CT regions
are highly variable, with CdiA sequences diverging abruptly after a
VENN peptide motif found within the conserved DUF638 domain
(Pfam PF04829). Similarly, CdiI sequences are also highly
variable, suggesting that these immunity proteins specifically bind
to cognate CdiA-CTs and neutralize their toxic activities. In
support of this model, we recently showed that CdiA-CTs from
Dickeya dadantii 3937 and uropathogenic E. coli (UPEC) 536 possess
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proteins bind to their cognate CdiA-CT and block nuclease
activity both in vitro and in vivo [5]. Thus, CdiA-CT/CdiI pairs
constitute a polymorphic family of toxin/immunity modules that
allow CDI systems to deploy a wide variety of growth inhibition
activities.
CdiA proteins share a number of characteristics with the Rhs
protein family. The rhs genes were first identified in E. coli by C.W.
Hill and colleagues, and were named rearrangement hotspots
based on their role in chromosome duplications [10,11]. Rhs
proteins are widely distributed throughout the eubacteria, but
their function is poorly understood. Like CdiA, Rhs proteins are
large, ranging from ,1,500 residues in Gram-negative bacteria to
over 2,000 residues in some Gram-positive species. Rhs proteins
also possess a central repeat region, though the characteristic YD
peptide repeats of Rhs proteins are unrelated to the hemagglutinin
repeats in CdiA. Moreover, Rhs proteins have variable C-terminal
domains that are sharply demarcated by a conserved peptide motif
(PxxxxDPxGL in the Enterobacteriaceae) [12]. Remarkably, we
find that some CdiA and Rhs proteins share related C-terminal
sequences, suggesting the protein families may be functionally
analogous. Rhs proteins from a number of species appear to be
exported to the cell surface [13–15], consistent with a role in cell-
to-cell communication.
Here we show that many CDI systems have an unusual genetic
organization similar to that described for some Rhs loci [12].
Downstream of the cdiBAI genes, CDI systems often contain
fragmentary gene pairs that resemble cdiA-CT/cdiI toxin/immu-
nity modules. The predicted cdiA-CT fragments generally lack
translation initiation signals but encode the VENN peptide motif
that demarcates the CdiA-CT region in full-length CdiA proteins.
These ‘‘orphan’’ CdiA-CT proteins possess growth inhibitory
activities, which are specifically neutralized by the corresponding
orphan CdiI immunity proteins. Moreover, we show that the
orphan cdiA-CT/cdiI region is actively transcribed in E. coli EC93.
Although the orphan CdiA-CT does not appear to be synthesized,
functional orphan CdiI immunity protein is produced in EC93.
We also show that the Rhs systems of D. dadantii 3937 encode
toxin/immunity pairs. Rhs-CTs from D. dadantii 3937 inhibit cell
growth when expressed in E. coli, and this toxic activity is
specifically neutralized by the cognate RhsI protein encoded
immediately downstream. These results suggest that Rhs consti-
tutes another class of cell-surface proteins involved in intercellular
competition, and that orphan CT/immunity modules may
represent a reservoir of toxin/immunity diversity for both CDI
and Rhs systems.
Results
Many CDI Systems Contain Orphan cdiA-CT/cdiI Gene
Pairs
Examination of the cdi locus in E. coli EC93 revealed two short
open reading frames (ORFs) immediately downstream of the cdiI
immunity gene (Figure 1). The first ORF lacks a translation
initiation codon but encodes the VENN motif that typically
demarcates variable CdiA-CT regions (Figure 1), suggesting the
first ORF encodes a detached CdiA-CT remnant and the second
ORF is its associated cdiI gene. A TBLASTN search of bacterial
genomes revealed that the encoded proteins are related to the
CdiA-CT/CdiI toxin/immunity pair from E. coli UPEC 536
(Figure S1). Thus, the cdiBAI gene cluster in E. coli EC93 is
followed immediately by an ‘‘orphan’’ cdiA-CT/cdiI module related
to the cdi locus of a different E. coli strain. To differentiate these
modules from main cdiBAI clusters, we indicate orphan genes with
a subscripted ‘‘o’’ and a number that indicates the position of the
module in the cdi locus. Additionally, throughout the text we will
indicate bacterial strains as superscripts. According to this




Examination of CDI regions in other bacteria shows that
orphan cdiA-CT/cdiI pairs are quite common. Although some CDI
systems are comprised solely of the cdiBAI gene cluster, many loci
are closely followed by one or more cdiA gene fragments that
usually encode the VENN peptide motif (Figure 2). These orphan
cdiA-CT genes are typically followed by small ORFs representing
potential cdiI immunity genes. For example, the region II CDI
system in Yersinia pseudotuberculosis PB1/+ contains four additional
cdiA-CT gene fragments encoding the VENN motif, each
associated with a putative cdiI gene (Figure 2 and Figure S2A).




PB1(II)) share significant regions of homology with the
upstream cdiA
PB1(II) gene. The extent of these homologous regions
varies between orphans, but the homology to full-length cdiA
PB1(II)
is limited to regions upstream of the VENN encoding sequences
for cdiA-CTo2
PB1(II) and cdiA-CTo3
PB1(II) (Figure S2 and Figure S3).
In contrast, the orphan cdiA-CTo1
PB1(II) gene shares no significant
identity with the full-length cdiA
PB1(II) gene beyond the sequence
encoding the VENN peptide (Figure S2C). Downstream of the
VENN encoding region, the orphan cdiA-CTo
PB1(II) genes are
unrelated to one another, but have homology to cdiA genes and
cdiA-CT fragments from other bacteria. The predicted orphan
CdiA-CTo1
PB1(II) (UniProt B2K3A6) is related to CdiA-CTs from
E. coli A0 34/86 (Q1RPM1; 87% identity over 107 residues) and
Enterobacter cloacae subsp. cloacae ATCC 13047 (D5CBA0; 50%
identity over 183 residues), as well as to orphan CdiA-CTs from
Dickeya zeae Ech1591 (C6CGV6; 88% identity over 111 residues)
and Citrobacter rodentium ICC168 (D2TJP2; 86% identity over 107
residues). Orphan CdiA-CTo2
PB1(II) (B2K3A4) is related to the
CdiA-CT from Serratia proteamaculans 568 (A8GK56; 63% identity
over 131 residues). Orphan CdiA-CTo3
PB1(II) (B2K3A2) is related
to a CdiA-CT from Erwinia amylovora CFBP1430 (D4HWF3; 63%
identity over 127 residues) and to orphan CdiA-CTs from E. coli
EC869 (B3BM80; 75% identity over 297 residues) and Neisseria
meningitidis MC58 (Q9K0T4; 57% identity over 136 residues).
Finally, orphan CdiA-CTo4
PB1(II) (B2K3A0) is related to the CdiA-
Author Summary
Recent work from our laboratories has shown that many
bacteria express contact-dependent growth inhibition
(CDI) systems in which stick-like proteins on the cell
surface deliver toxic tips into target cells. Over 60 distinct
toxic tips have been identified in bacteria, and our data
indicate that each CDI
+ cell expresses a specific immunity
protein that binds to its cognate toxin and inactivates it to
prevent cell suicide. Here we identify genes for toxic tips
that are not attached to the stick protein. Each of these
‘‘orphan’’ tips has toxic activity, which is blocked by its
associated immunity protein. Remarkably, the orphan tips
of some bacterial species are often found on the stick
proteins in other species, suggesting that cells load and
deliver different tips. We also report on a system called
Rhs, which encodes another predicted stick-like protein
that also carries variable tips. We found that the tips of Rhs
proteins are toxic and that Rhs systems encode immunity
proteins that specifically block toxin activity. CDI and Rhs
toxin tip diversity may represent a microbial arms race,
driven by the competition for environmental resources.
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PB1(II) gene (39% identity over
179 residues), and also to CdiA-CTs from Klebsiella pneumoniae 342
(B5Y0C2; 61% identity over 263 residues) and Dickeya dadantii
Ech586 (D2BZ75; 59% identity over 263 residues).
Although some CDI systems, such as those in Y. pseudotuberculosis
PB1/+ and Neisseria meningitidis FAM18, have well-ordered arrays
of orphan cdiA-CT gene fragments downstream of cdiBAI, other
species have more complex genomic arrangements. Klebsiella
Figure 1. E. coli EC93 contains an orphan cdiA-CT/cdiI module. The CDI region of E. coli EC93 is depicted, with cdiB, cdiA and cdiI genes shown
in yellow, green and purple, respectively. The cdiA coding region upstream of the encoded VENN motif is shown in light green, and the cdiA-CT
sequence is shown in dark green. The orphan cdiA-CT fragment (cdiA-CTo1) and orphan cdiI (cdiIo1) are dark green and purple, respectively. The
nucleotide sequence of the cdiI - cdiA-CTo1 junction and the predicted reading frames are shown in detail. Sequences similar to transposable element
genes are shown in red.
doi:10.1371/journal.pgen.1002217.g001
Figure 2. Many bacteria contain orphan cdiA-CT/cdiI modules. The cdi loci from selected bacterial species are presented using the color-
coding scheme in Figure 1. Arrowheads indicate the positions of VENN encoding regions. Probable orphan cdiA-CT/cdiI modules are indicated with an
‘‘o’’ and numeral. Note the change in scale for the locus from E. coli EC869. The UniProt accession numbers for the encoded CdiA proteins are:
Escherichia coli 254 ser. O113:H21 (A1XT91); Edwardsiella ictaluri 93–146 (C5BAK2); Erwinia pyrifoliae DSM 12163 (D2T668); Edwardsiella tarda EIB202
(D0ZDG0); Klebsiella variicola At-22 (D3RCW8); Neisseria menigitidis FAM18 (A1KSB8); Photorhabdus asymbiotica ATCC 43949 (B6VKN5); Pectobacterium
wasabiae WPP163 (D0KFH4); Yersinia pseudotuberculosis PB1/+ (B2K3A8); and Escherichia coli EC869 (B3BM48). The E. coli 254 genomic sequence does
not include the 59-end of the cdiA gene.
doi:10.1371/journal.pgen.1002217.g002
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CT fragments that do not encode VENN and lack associated cdiI
genes (Figure 2). In several instances, the orphan cdiA-CT genes are
disrupted by IS elements and transposon genes. For example, the
orphan cdiA-CTo9
EC869 from E. coli EC869 is interrupted by an
SSuT antimicrobial resistance element [16]. Orphan cdiA-CT
fragments can retain varying amounts of cdiA sequence upstream
of the VENN-encoding region, but in some cases these
homologous sequences are absent (Figure 2). For example, the
orphan cdiA-CTo7
EC869 gene from E. coli EC869 is unrelated to the
adjacent cdiA-CTo
EC869 fragments, but is almost identical (99%
identity from the VENN region onward) to the orphan cdiA-
CTo1
254 from E. coli strain 254 (Figure S4). Moreover, the
associated cdiI immunity genes are also nearly identical. A
comparison of the E. coli EC869 and E. coli strain 254 genomes
shows that the homology between these orphan cdiA-CT/cdiI
modules begins at the VENN encoding sequence and extends
precisely to the VENN sequence of the next cdiA-CT orphan
(Figure S4).
Interchange of cdiA-CT/cdiI Modules
All sequenced Y. pestis strains share two large blocks of
conserved DNA that contain cdi loci. For the region I CDI system
(positioned between the mannitol transporter and dioxygenase b-
subunit genes), the predicted CdiA
(I) protein is identical in all fully
sequenced Y. pestis strains with the exception of the Microtus
91001 strain. CdiA
(I) sequences N-terminal to the VENN motif are
essentially identical in Microtus 91001 and other Y. pestis strains,
though there is a six amino acid residue deletion within the
hemagglutinin repeat region of Microtus 91001. However,
following the VENN motif, the CdiA-CT
91001(I) of Microtus
91001 diverges from that of other Y. pestis strains (Figure S5).
Pairwise comparison of the Y. pestis CO92 and Y. pestis Microtus
91001 genomes revealed a 3,557 base-pair deletion in the
Microtus 91001 region I cdi locus that has fused an orphan cdiA-
CT/cdiI module to the upstream cdiA
91001(I) gene (Figure 3A),
producing a CdiA/CdiI toxin/immunity pair that is different from
other Y. pestis strains. Thus, the CdiA
91001(I) protein from Microtus
91001 contains an orphan CdiA-CT effector domain from the
CO92 strain.
Another possible example of CdiA-CT interchange is found in
the region II CDI system (located between tellurium resistance
genes and a predicted autotransporter) shared by Y. pseudotubercu-
losis PB1/+ and IP31758 strains. The main cdiA-CT
IP31758(II) and
cdiI
IP31758(II) sequences of Y. pseudotuberculosis IP31758 are essen-
tially identical to the cdiA-CTo4
PB1(II)/cdiIo4
PB1(II) orphan module
from strain PB1/+ (99% identity over 3,646 nucleotides)
(Figure 3B). Additionally, comparison of these loci revealed other
complex rearrangements. The orphan cdiA-CTo1
PB1(II)/cdiIo1
PB1(II)
module of strain PB1/+ is nearly identical to cdiA-CTo2
IP31758(II)/
cdiIo2
IP31758(II) from IP31758 (98% identity over 2,656 nucleotides),
and the orphan cdiA-CTo2
PB1(II)/cdiIo2
PB1(II) from PB1/+ is 98%
identical (over 1,073 nucleotides) to a cdiA gene fragment (which
lacks the VENN encoding sequence) and its associated cdiI gene in
strain IP31758 (Figure 3B). There are at least two possible
explanations for these observations. The two Y. pseudotuberculosis
strains could have independently acquired the same modules and
incorporated them at different sites within the cdi locus.
Alternatively, the cdi locus of a common ancestor may have
rearranged during strain diversification. Although the mechanisms
underlying these complex exchanges are unknown, these obser-
vations suggest that orphan cdiA-CT fragments are a potential
source of CdiA/CdiI toxin/immunity diversity.
Orphan cdiA-CT/cdiI Modules Are Functional
If orphan cdiA-CT/cdiI modules are merely unused, nonfunc-
tional remnants of full-length cdiA/cdiI genes, then there should be
no selective pressure to maintain CdiA-CT toxin activity and CdiI
immunity function. To determine whether orphan cdiA-CT/cdiI
modules encode functional proteins, we characterized the orphan
CdiA-CT/CdiI proteins from E. coli EC93. As described above,
CdiA-CTo1
EC93 and CdiIo1
EC93 are very similar to the UPEC 536
CdiA-CT
UPEC536/CdiI
UPEC536 pair that we have previously
characterized [5]. We first tested whether CdiA-CTo1
EC93 and
CdiIo1
EC93 bind to one another as predicted for a toxin/immunity
pair. We introduced a translation initiation signal upstream of the
cdiA-CTo1
EC93 fragment and co-expressed orphan CdiA-CTo1
EC93
with CdiIo1
EC93 immunity protein carrying a hexa-histidine (His6)
epitope tag at its C-terminus. Ni
2+-affinity purification of His6-
tagged CdiIo1
EC93 under non-denaturing conditions resulted in co-
purification of CdiA-CTo1
EC93 (data not shown), demonstrating
that the two proteins bind each other. Given the similarity
between CdiA-CTo1
EC93 and CdiA-CT
UPEC536, we next tested
whether the CdiI
UPEC536 and CdiIo1
EC93 immunity proteins are
able to bind near-cognate CdiA-CTs. His6-tagged CdiI proteins
were first separated from their cognate CdiA-CT proteins by Ni
2+-
affinity chromatography under denaturing conditions. The
individual proteins were then refolded and tested for binding to
their cognate partners. Refolded CdiA-CTo1
EC93 and CdiA-
CT
UPEC536 were able re-bind to their cognate CdiI proteins
(Figure 4A). However, the His6-tagged CdiI proteins were unable
to bind stably to the near-cognate CdiA-CTs (Figure 4A). These
results show that the EC93 orphan CdiA-CT/CdiI proteins
physically interact with one another, but appear to have diverged
enough from the UPEC 536 system that high-affinity binding
between the two systems no longer occurs.
We previously demonstrated that CdiA-CT
UPEC536 is a nuclease
that cleaves tRNA [5]; therefore we asked whether CdiA-
CTo1
EC93 also possesses this biochemical activity. Purified CdiA-
CTo1
EC93 cleaved a number of different tRNA species in a manner
that was indistinguishable from CdiA-CT
UPEC536 tRNase activity
(Figure 4B and data not shown). This tRNase activity was
inhibited by the addition of equimolar His6-tagged CdiIo1
EC93
(Figure 4B). Intriguingly, His6-tagged CdiI
UPEC536 was also able to
neutralize the tRNase activity of CdiA-CTo1
EC93, but CdiIo1
EC93
had no effect on CdiA-CT
UPEC536 activity (Figure 4B). Presum-
ably, CdiI
UPEC536 interacts with CdiA-CTo1
EC93, but this binding
is not of sufficient affinity to allow co-purification by Ni
2+-affinity
chromatography. Together, these results show that the EC93
orphan CdiA-CT/CdiI proteins retain the biochemical features of
a functional toxin/immunity module.
Orphan CdiA-CTs Inhibit Cell Growth
We next asked whether the EC93 orphan CdiA-CT retains
growth inhibitory activity. In general, cdiA-CT gene fragments are
very toxic and can only be maintained on plasmids if the cognate
cdiI immunity gene is also present. However, CdiI immunity
proteins efficiently block CdiA-CT activity, making it difficult to
assess CdiA-CT toxicity. To circumvent this problem, we used the
controllable proteolysis system of McGinness and Sauer [17] to
activate CdiA-CTo1
EC93 through degradation of the CdiIo1
EC93
immunity protein. This strategy uses the SspB adaptor protein to
deliver ssrA(DAS) peptide-tagged proteins to the ClpXP protease.
We tagged the C-terminus of CdiIo1
EC93 with the ssrA(DAS)
peptide and co-expressed it with CdiA-CTo1
EC93 in E. coli DsspB
cells. Degradation of tagged CdiIo1
EC93 was then initiated by
induction of SspB synthesis from a plasmid-borne arabinose-
inducible promoter, resulting in growth arrest after approximately
Toxin Effectors of CDI and Rhs Systems
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induction of SspB(D47) (Figure 5A), which lacks the C-terminal
motif required for binding to ClpXP. Analysis of total cellular
RNA revealed cleavage of tRNAs in the cells expressing wild-type
SspB, but not in those expressing SspB(D47) (Figure 5B). These
results demonstrate that CdiA-CTo1
EC93 activity is unmasked
upon CdiIo1
EC93 degradation. Additionally, the temporal correla-
tion between growth arrest and tRNA cleavage strongly suggests
that the tRNase activity of CdiA-CTo1
EC93 is responsible for
growth inhibition.
To test whether other orphan cdiA-CT/cdiI modules have
growth inhibition activity, we examined orphan gene pairs from
Dickeya dadantii 3937 and E. coli EC869. D. dadantii 3937 contains
one orphan cdiA-CT/cdiI module in the region I cdi locus. We
cloned this module and added a C-terminal His6 epitope tag onto
the predicted CdiIo1
3937 protein. Overproduced CdiA-CTo1
3937
protein co-purified with CdiIo1
3937-His6 during Ni
2+-affinity
chromatography, indicating a binding interaction between these
proteins (Figure S6A). Moreover, CdiA-CTo1
3937 inhibited the
growth of E. coli cells upon degradation of ssrA(DAS)-tagged
CdiIo1
3937 (Figure S6B). Examination of the orphan cdiA-CTo11/
cdiIo11 module from E. coli EC869 gave similar results, except
growth inhibition was delayed compared to the D. dadantii 3937
orphan system (Figure S6). These data demonstrate that other
orphan cdiA-CT/cdiI modules also encode functional toxin/
immunity pairs.
The EC93 orphan cdiA-CTo1
EC93 lacks translation initiation
signals, suggesting the encoded protein is not synthesized under
normal conditions. By analogy with other two-partner secretion
proteins, full-length CdiA proteins are secreted through the inner
membrane via the general secretory pathway and assembled onto
the cell surface through interactions with CdiB [4,18]. The EC93
orphan cdiA-CTo1
EC93 gene also lacks a signal sequence and thus
would not be delivered to the cell surface if it were expressed.
Therefore to test whether CdiA-CTo1
EC93 and CdiIo1
EC93 are
functional in the context of cell-mediated CDI, we replaced the
EC93 cdiA-CT
EC93/cdiI
EC93 region with the corresponding se-
quences from the EC93 orphan module. The resulting construct
Figure 3. Interchange between cdiA and orphan cdiA-CTs. A) ACT comparison of the CDI systems (region I) from Y. pestis CO92 (top) and
Y. pestis Microtus 91001 (bottom). The cdi loci lie within a highly conserved genomic region (red blocks denote nucleotide conservation), but the
sequences encoding CdiA-CT diverge beginning at the VENN region. A 3,557 bp deletion in Y. pestis Microtus 91001 has fused the orphan cdiA-CT/cdiI
module to the full-length cdiA gene (highlighted in yellow). B) ACT comparison of region II cdi loci from Y. pseudotuberculosis strains IP31758 (top)
and PB1/+ (bottom). The cdi loci lie within a highly conserved genomic region (red denotes nucleotide conservation), but the cdiA-CT sequences
exhibit complex rearrangements between the two strains. The orphan cdiA-CTo4
PB1(II)/cdiIo4
PB1(II) module of strain PB1/+ is essentially identical to the
cdiA-CT
IP31758(II) and cdiI
IP31758(II) sequences from strain IP31758 (99.1% identity over 3,648 nucleotides; highlighted in yellow). Additionally, the orphan
cdiA-CTo1
PB1(II)/cdiIo1
PB1(II) module is nearly identical to the orphan cdiA-CTo2
IP31758(II)/cdiIo2
IP31758(II) module (98% identity over 2,656 nucleotides,
highlighted in blue), and the cdiA-CTo2
PB1(II)/cdiIo2
PB1(II) module is nearly identical to a cdiA fragment (and associated cdiI gene) found between the
two orphan modules in strain IP31758 (98% identity over 1,073 nucleotides; highlighted in green).
doi:10.1371/journal.pgen.1002217.g003
Toxin Effectors of CDI and Rhs Systems
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EC93 is
fused to CdiA
EC93 at the VENN motif (Figure 6A). E. coli
expressing the CdiA
EC93-CTo1
EC93 chimera inhibited the growth
of target cells expressing the CdiI
EC93 immunity protein ,10
5-fold
compared to control CDI
2 inhibitor cells, but target cells
expressing the orphan CdiIo1
EC93 were completely protected from
growth inhibition (Figure 6B). In contrast, CdiIo1
EC93 was unable
to protect target cells from growth inhibition mediated by
CdiA
EC93 (Figure 6B). Thus, the EC93 orphan CdiA-CTo1 is
functional in contact-dependent growth inhibition when it is part
of a full-length CdiA protein.
The Orphan CdiI Immunity Protein Is Expressed in EC93
To determine whether orphan cdiA-CT/cdiI modules are
expressed, we isolated total RNA from E. coli EC93 and performed






(Figure 7). This analysis revealed that transcripts encoding orphan
cdiA-CTo1
EC93 and cdiIo1
EC93 are expressed in wild-type EC93
cells, and that orphan message levels are very similar to those
encoding the main cdiA-CT
EC93 and cdiI
EC93 (Figure 7). Addition-
ally, the orphan transcript was expressed at approximately the
same level in an EC93 strain deleted for the main cdiA-CT
EC93/
cdiI
EC93 region (Figure 7), indicating that the promoter driving
orphan region transcription is upstream of the main cdiA-CT
EC93.
These results suggest that the orphan region is co-transcribed with
the upstream cdiA and cdiI genes. Indeed, a large RT-PCR product
was obtained with the forward cdiA
EC93 and reverse cdiA-CTo1
EC93
primers (data not shown), confirming that all of these ORFs are
present on a single transcript. We next sought to detect the CdiA-
CTo1
EC93 protein by immunoblot using polyclonal antibodies
raised against the homologous CdiA-CT
UPEC536 from UPEC 536.
Although this antiserum detects CdiA-CTo1
EC93 produced from a
heterologous expression system in E. coli K-12, we were unable to
detect CdiA-CTo1
EC93 in whole-cell lysates of EC93 (data not
shown).
In contrast to the orphan cdiA-CTo1
EC93 fragment, the EC93
cdiIo1
EC93 gene has an initiation codon and a properly spaced
Shine-Dalgarno sequence, indicating that the CdiIo1
EC93 protein is
likely to be synthesized in EC93 cells. To determine if orphan
CdiIo1
EC93 is indeed expressed, we tested whether EC93 cells are
resistant to CDI mediated by the chimeric CdiA
EC93-CTo1
EC93
protein. Because EC93 cells are CDI
+, the chimeric inhibitor
strain must itself be immune to EC93-mediated CDI. Therefore,
we introduced a cosmid encoding the CdiA
EC93-CTo1
EC93
chimera into EC93 and used the resulting strain as the inhibitor
for these experiments. Wild-type EC93 was not inhibited by EC93
expressing the CdiA
EC93-CTo1
EC93 chimera, but the EC93 DcdiA-
CTo1
EC93/DcdiIo1
EC93 strain was inhibited approximately 10
3-fold
(Figure 8). This growth inhibition was completely abrogated when
orphan CdiIo1
EC93 immunity protein was expressed from a
plasmid in the EC93 DcdiA-CTo1
EC93/DcdiIo1
EC93 cells (Figure 8).
Taken together, these results demonstrate that functional
CdiIo1
EC93 immunity protein is produced from the orphan locus
in EC93.
rhs Loci Encode Orphan Toxin/Immunity Modules
In the course of our bioinformatic analyses, we found that many
CdiA-CT sequences share significant identity with the C-terminal
regions of Rhs proteins (Table S1). For example, the CdiA-
CT
91001(I) of Y. pestis Microtus strain 91001 (Q74T84) is similar to
the C-terminal region of an Rhs/YD-repeat protein from Waddlia
chondrophila WSU 86–1044 (D6YTT8) (Table S1 and Figure S7).
The W. chondrophila rhs gene is followed by a small ORF that
encodes a protein with similarity to CdiI
91001(I) from Y. pestis
Microtus 91001 (27% identity over 48 residues), suggesting this
locus encodes a toxin/immunity protein pair. Intriguingly, Rhs-
CT sequences are variable and demarcated by a well-conserved
Figure 4. The tRNase activity of CdiA-CTo1
EC93 is blocked by the binding of CdiIo1
EC93. A) Analysis of CdiA-CT/CdiI binding. Purified CdiA-
CT and CdiI-His6 proteins were mixed at equimolar ratios then purified by Ni
2+-affinity chromatography. Input samples represent the protein mixtures
prior to chromatography. Unbound fractions contain proteins that failed to bind the affinity resin. Bound proteins were eluted from the affinity resin
with imidazole. All fractions were analyzed by SDS-PAGE. B) Northern blot analysis of CdiA-CT
UPEC536 and CdiA-CTo1
EC93 tRNase activity. S100 fractions
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CdiA proteins [12,19]. The parallels between CDI and Rhs
systems extend to their genetic organization, with many rhs loci
containing numerous ‘‘silent cassettes’’ that resemble CDI orphan
modules [12]. Rhs systems also appear to undergo complex
rearrangements that diversify Rhs-CT sequences. For example, in
one Rhs region shared by Y. pseudotuberculosis strains IP31758 and
IP32953, the rhs-CT and putative rhsI sequences are completely
unrelated to one another, but the surrounding genomic regions are
clearly homologous between the strains (Figure 9). This homology
includes rhs coding sequence upstream of the region encoding
DPxGL and nearly identical rhs-CT/rhsI orphan modules
downstream of the rhs genes (Figure 9 and Figure S8). In addition,
orphan rhs-CT/rhsI modules from a given species are often found
fused to full-length rhs genes in other bacteria. For example, one of
the rhs loci in D. dadantii 3937 contains two orphan rhs-CT/rhsI
modules. Both of these predicted orphan Rhs-CT
3937 proteins are
related to the C-terminal regions of full-length Rhs proteins: Rhs-
CTo1
3937 (E0SGM0) is related to the CT region of a putative Rhs
repeat protein (C3K5K6; 49% identity in 147 residues following
the DPxGL) from Pseudomonas fluorescens SBW25, and Rhs-
CTo2
3937 (E0SGM2) is related to the CT of a predicted YD-
repeat protein (C6CNW6; 99% identity in 116 residues) from
Dickeya zeae 1591.
In general, the functions of Rhs proteins are unknown, but data
from Hill and colleagues suggest that that the E. coli rhsA locus may
encode a toxin/immunity pair [20]. In conjunction with the
Figure 5. CdiA-CTo1
EC93 inhibits the growth of E. coli cells. A)
Growth curves of E. coli DsspB cells expressing CdiA-CTo1
EC93/CdiIo1
EC93-
DAS. Degradation of CdiIo1
EC93-DAS was initiated by the addition of L-
arabinose to induce SspB synthesis. Control cells express SspB(D47),
which does not deliver CdiIo1
EC93-DAS to the ClpXP protease. Growth
curves with square symbols represent control strains expressing SspB or
SspB(D47), but not CdiA-CTo1
EC93/CdiIo1
EC93-DAS. B) Analysis of in vivo
CdiA-CTo1
EC93 tRNase activity. Total RNA was isolated from cells
expressing CdiA-CTo1
EC93/CdiIo1
EC93-DAS at varying times after L-
arabinose induction. Samples were run on polyacrylamide gels followed
by staining with ethidium bromide (EtBr) or Northern blot analysis using




Figure 6. The EC93 orphan cdiA-CT/cdiI module is functional in
contact-dependent growth inhibition (CDI). A) The wild-type
EC93 and orphan chimera CDI systems are shown schematically. The
cdiA-CT
EC93/cdiI
EC93 region was deleted and orphan module fused onto
the cdiA
EC93 gene at the VENN encoding sequence. B) Growth
competitions. CDI
+ inhibitor cells were co-cultured with target cells
expressing either CdiI
EC93 or orphan CdiIo1
EC93 immunity proteins.
Viable target cells were quantified by plating on selective media to
determine the number of colony forming units (cfu) per milliliter.
doi:10.1371/journal.pgen.1002217.g006
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proteins may be involved in intercellular competition. To test
whether other Rhs systems encode toxin/immunity pairs, we
examined rhs genes from D. dadantii 3937, which contains three
full-length rhs genes that we have termed rhsA (Dda3937_01758),
rhsB (Dda3937_02773) and rhsC (Dda3937_04312). Each of these
rhs genes is closely followed by a small ORF that encodes a possible
immunity protein. Additionally, the rhsC locus contains the two
orphan rhs-CT gene fragments described above. We first tested
RhsB-CT
3937 for growth inhibitory function, because this domain
contains an HNH endonuclease motif found in other cytotoxic
proteins [21]. We expressed RhsB-CT
3937 together with an
ssrA(DAS)-tagged version of the putative RhsIB
3937 immunity
protein in E. coli cells, and found that growth was arrested upon
degradation of RhsIB
3937-(DAS) (Figure 10 and data not shown).
The same results were obtained with the two orphan modules
from D. dadantii 3937 (Figure 10 and data not shown), indicating
that Rhs-CTo1
3937 and Rhs-CTo2
3937 also have growth inhibition
activity. These results also demonstrate that the putative rhsI genes
do in fact encode proteins with immunity function.
Finally, we examined the specificity of RhsI-mediated immu-
nity. Although each Rhs-CT/RhsI-(DAS) expression construct can
be maintained stably in E. coli DsspB strains, these plasmids cannot
be transformed into sspB
+ cells due to the Rhs-CT toxicity that
results from RhsI-(DAS) degradation (Figure 10 and data not
shown). Therefore, we asked whether untagged RhsI protein could
rescue cells from Rhs-CT toxicity and allow stable transformation
of Rhs-CT/RhsI-(DAS) plasmids into sspB
+ cells. Each of the three
Rhs-CT/RhsI-(DAS) plasmids were introduced into sspB
+ cells
expressing individual RhsI proteins, and the transformed cell
suspensions plated onto selective media containing L-arabinose to
induce Rhs-CT/RhsI-(DAS) synthesis. Transformants carrying
the Rhs-CT/RhsI-(DAS) expression plasmid were only obtained if
the cells also expressed the cognate RhsI immunity protein
(Figure 10). Therefore, each RhsI protein only confers immunity
to its cognate Rhs-CT, demonstrating that the Rhs systems of D.
dadantii 3937 encode polymorphic toxin/immunity pairs.
Discussion
The results presented here show that many CDI systems have a
complex genetic organization in which the cdiBAI genes are
Figure 7. The EC93 orphan region is transcribed. RNA from E. coli EC93, EC93 DcdiA-CT
EC93DcdiI
EC93, and EC93 DcdiA-CTo1
EC93DcdiIo1
EC93 was
subjected to quantitative RT-PCR. The primer binding sites within the cdi locus are depicted schematically as arrows. The relative expression levels
represent the mean 6 SEM for three independently isolated RNA samples.
doi:10.1371/journal.pgen.1002217.g007
Figure 8. The EC93 orphan region produces functional CdiIo1
immunity protein. EC93 expressing chimeric CdiA
EC93-CTo1
EC93 was
used as an inhibitor strain in growth competition experiments. Inhibitor
cells were co-cultured with wild-type EC93, EC93 deleted for the orphan
region (DcdiA-CTo1
EC93DcdiIo1
EC93), and EC93 DcdiA-CTo1
EC93DcdiIo1
EC93
cells complemented with a plasmid-borne copy of cdiIo1
EC93 (cdiIo1
+).
Viable target cells were quantified by plating on selective media to
determine the number of colony forming units (cfu) per milliliter.
doi:10.1371/journal.pgen.1002217.g008
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arrays can be extensive, with eleven orphan gene pairs in the cdi
locus of E. coli EC869. The widespread occurrence of orphan cdiA-
CT/cdiI modules in diverse bacterial species argues that these gene
pairs confer a selective advantage. Although the majority of
orphan cdiA-CT genes lack translation initiation signals, orphan
cdiI genes appear to be fully capable of expression. Therefore,
bacteria could maintain orphan modules to build a repertoire of
immunity genes to protect themselves from neighboring bacteria
that express diverse CdiA proteins. Broad range immunity would
clearly confer an advantage and our data demonstrate that EC93
does in fact express its orphan CdiI immunity protein. However, if
bacteria are collecting immunity genes, then it is unclear why the
toxin-encoding cdiA-CT fragments are retained in the process. One
model to explain these findings is that orphan modules allow the
bacterium to change its toxin/immunity profile by recombination
between the highly conserved VENN-encoding sequences. This
may have occurred in the cdi locus of Y. pestis Microtus 91001,
where a large deletion has loaded an orphan cdiA-CT/cdiI module
onto the main cdiA gene. However, such a strategy for generating
CdiA-CT diversity could have serious shortcomings. First,
although reloading CdiA with a new toxic C-terminal domain
would produce a novel weapon, the recombination would also
delete cdiI and render the cell susceptible to the original CdiA
protein expressed by neighboring bacteria that have not
recombined their cdi locus. Second, simple recombination between
cdiA and distal orphan cdiA-CT genes would delete all intervening
cdiA-CT/cdiI modules. An alternative model is that recombination
between cdiA (or rhs) and the orphan regions occurs following
tandem duplication of the loci. This mechanism would allow cdiA-
CT/cdiI modules to be rearranged without the loss of immunity or
genetic diversity, because a copy of the original cdi/rhs system
would be present [22,23].
The results presented here have also revealed a connection
between CDI and Rhs systems. The rhs genes were first described
in E. coli, and were originally thought to be rearrangement hot
spots because of a recombination event between nearly identical
sequences within the rhsA and rhsB genes [10,11]. These proteins
are widely distributed throughout the eubacteria and related
proteins containing YD peptide repeats are also found in
metazoans including all vertebrates. Despite their prevalence,
the function of these proteins is almost completely unknown. Our
data show that at least some Rhs systems encode toxin/immunity
protein pairs, and a recent bioinformatic study has proposed that
Rhs proteins contain toxic nuclease domains [24]. These results
are consistent with work from Hill and colleagues showing that the
C-terminal region of E. coli RhsA blocks the recovery of stationary
phase cells [20]. Moreover, this growth inhibition was neutralized
by expression of the ORF (yibA) encoded immediately downstream
of rhsA [20]. More recently an Rhs-related protein from
Pseudomonas savastanoi pv. savastanoi was found to be associated
with bacteriocin activity [25]. Because of the parallels between
CDI and Rhs, we suspect that Rhs proteins are also exported to
block the growth of neighboring cells and thereby impart a
competitive advantage to the inhibitor cell. However, many Rhs
proteins from Gram-negative bacteria lack recognizable signal
sequences, so the export pathway is unclear in several instances.
Many rhs genes are linked to valine-glycine repeat (Vgr)-encoding
genes that are associated with Type VI secretion systems [26].
VgrG proteins associated with Type VI secretion systems have
structural similarity to bacteriophage cell-puncturing proteins
[27,28], and are therefore ideal for penetrating bacterial
envelopes. Indeed, recent work has demonstrated that Type VI
systems are used to deliver protein toxins into target bacteria [29].
Whether the close genetic linkage between rhs and vgr genes
extends to a functional relationship remains to be determined.
Although the Rhs systems examined here appear to be growth
inhibitory, there are indications that Rhs proteins have other
signaling modalities. Youdarian and Hartzell found that an Rhs-
related YD repeat protein (Q1CXS7) from Myxococcus xanthus plays
an important role in social motility [15], which occurs when
individual bacteria make contact with one another to coordinate
cell movement. The M. xanthus YD repeat protein has a signal
sequence and is presumably exported to the surface. The gene
encoding Q1CXS7 (MXAN_6679) is closely followed by a small
ORF that is suggestive of an rhsI gene. However, it is not clear that
immunity would be required in this signaling pathway. Perhaps
this small ORF encodes a peptide that is involved in receiving the
Figure 9. Rhs genes have variable CT encoding sequences, immunity genes, and orphan rhs-CT/rhsI modules. ACT comparison of
related Rhs regions from Y. pseudotuberculosis strains IP31758 (top) and IP32953 (bottom). This region is highly conserved between the two strains,
but the rhs genes encode unrelated CT sequences and the adjacent rhsI genes are unrelated. Both strains contain a related orphan rhs-CT/rhsI
module. The orphan module in strain IP32953 has more upstream rhs coding sequence, but contains an in-frame stop codon in this retained
sequence. The vgrG gene is a conserved component of Type VI secretion systems; TPR is a conserved gene encoding a potential tetratricopeptide
repeat protein; and X and Y are conserved predicted genes of unknown function.
doi:10.1371/journal.pgen.1002217.g009
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Recent work on the entomopathogen Pantoea stewartii suggests
another function for a class of Rhs-related proteins termed Ucp
(for you cannot pass) [30]. The P. stewartii genome contains seven
ucp homologs that encode large proteins (1,200–1,300 residues)
with similar N-terminal regions and variable C-terminal sequenc-
es. The Ucp1 protein mediates bacterial aggregation and is a
virulence factor required for pathogenicity against the aphid host.
It was postulated that Ucp1 and other Ucp proteins function
primarily as adhesins and that C-terminal variability is driven by
the need to evade host immune responses [30]. Our results suggest
an alternative possibility. The C-terminal peptide of Ucp1 could
be delivered into insect cells and exert a toxic effect in a manner
similar to that proposed for CDI [5]. In this model, the other six
Ucp proteins could be targeted against other bacterial competitors
or different eukaryotic hosts.
Finally, another intriguing example of Rhs signaling has been
proposed for teneurins. The teneurin protein family is comprised
of four paralogs that are present in all vertebrates [31]. These
proteins are type II integral membrane proteins (single transmem-
brane span with the C-terminus presented extracellularly) that
play a role in axon guidance and neural patterning during
development [31,32]. Like Rhs proteins, the teneurins are large
(2,500–2,800 residues) and the C-terminal half is comprised of
several YD peptide repeats. Remarkably, all teneurins contain a
C-terminal associated peptide (TCAP) that is similar to neuroen-
docrine signaling peptides [33,34]. The TCAP region is adjacent
to a phylogenetically conserved furin protease cleavage site
(RxRR) [31], suggesting that the TCAPs are released and enter
target cells to exert neuromodulatory effects. Because some CdiA-
CTs and Rhs-CTs have toxic nuclease activity, presumably they
must also be cleaved for delivery into the cytoplasm of target cells.
The parallel between CDI/Rhs-mediated growth inhibition and
the proposed teneurin signaling pathway is striking, suggesting that
intercellular communication through the delivery of cleaved C-
terminal peptides is ubiquitous and possibly ancient. Perhaps these
systems have arisen from a common YD-repeat protein ancestor.
Materials and Methods
Bioinformatic Analysis
Pairwise sequence comparisons were performed using GCG
Gap or pairwise BLAST. Related CdiA-CT, Rhs-CT, CdiI, RhsI
and orphan sequences were found using TBLASTN against
assembled bacterial genomes, because these regions are often not
annotated and thus not represented in the non-redundant protein
database. Pairwise comparisons of genomic regions were per-
formed using WebACT (www.webact.org) with BLASTN com-
parisons. The UniProt, GenBank and gene locus accession
numbers for each full-length CdiA and Rhs protein discussed in




EC93 module from E. coli EC93
was amplified using oligonucleotides, EC93orph-Nco (59 - TTG
CCA TGG AGA ATA ACT CGC TGA GC) and EC93orph-
Spe (59 - ATC ACT AGT GGC ATT AGA TAG CTT ATC
TAT TTT TGC) (restriction endonuclease sites are underlined),
followed by digesting with NcoI and SpeI, and ligation to plasmid
pET21S [5]. The resulting construct overproduces CdiA-
CTo1
EC93 and C-terminally His6-tagged CdiIo1
EC93. The EC93
orphan immunity gene was amplified using primers #1658 (59 -
CAA CAA GCA TGC CCC GAC TTT GAG ACC AGA ATA
TC) and #1664 (59 - ATC AGG AGC ATG GTA TAT GAC
AAC ATT TAG ATC). The resulting PCR product was digested
with SphI and ligated to EcoRV/SphI digested plasmid pBR322
under control of the tet promoter.
Orphan cdiA-CT/cdiI modules from D. dadantii 3937 and E. coli
EC869 were amplified using 3937orph-Nco (59 - AAG CCA
TGG TGG AGA ATA ACT ATC TGA GCA G) and
3937orph-Spe (59 - TCT ACT AGT AGG CTG GTA ATC
TTC ATA TTC C); and EC869orph11-Nco (59 - ATT CCA
TGG GCA CAA ACC AGT CTC TGA CCT TCG) and
EC869orph11-Spe (59 - TCT ACT AGT ACC TTT GCA
GCG ACT CAA GGC CAG), respectively. The rhs-CT
3937/
rhsI
3937 modules from D. dadantii 3937 were amplified using the
following primer pairs: rhsB-Nco (59 - CAG CCA TGG AAA
Figure 10. The Rhs genes of D. dadantii 3937 encode toxin/
immunity pairs. E. coli sspB
+ cells expressing RhsI
3937 proteins were
incubated with supercoiled plasmids encoding the various Rhs-CT
3937/
RhsI
3937-DAS pairs and plated to select stable transformants. All Rhs-
CT
3937/RhsI
3937-DAS constructs were also introduced into E. coli DsspB
cells to demonstrate that RhsI
3937-DAS degradation is required for
growth inhibition.
doi:10.1371/journal.pgen.1002217.g010
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CTA GTA ATT TTT CTT GAT TTA TAT TTT ACA AGC);
rhs-orph1-Nco (59 -T C C CAT GGG GTT GGT GGG ATG
TCC GC) and rhs-orph1-Spe (59 - AAA ACT AGT GCC ATC
AAG GTA TAC AGA AGG); and rhs-orph2-Nco (59 - ACC
CCA TGG GGC TGG CAG GGG GGC TG) and rhs-orph2-
Spe (59 - TTT ACT AGT AAC AGC TTT GTA ATA ATC
GTG). All PCR products were digested with NcoI and SpeI and
ligated to pET21S. The D. dadantii rhsI
3937 genes were amplified
from pET21S constructs using primer pET-Pst (59 - CGG CTG
CAG CAG CCA ACT CAG TGG) in conjunction with primers:
rhsIB-Nco (59 - TAA CCA TGG ATA TTG AAA ATG C),
rhsIo1-Nco (59 - TCA CCA TGG ATT CTA GTG ATA AG),
and rhsIo2-Nco (59 - AAT CCA TGG ATG CTG AAC AAT
TTG). The resulting PCR products were digested with NcoI and
PstI and ligated to plasmid pCH450 [35].
A cassette encoding the ssrA(DAS) peptide tag (AANDENY-
SENYADAS) was generated from oligonucleotides, DAS-top (59 -
CTA GTG CTG CGA ACG ATG AAA ATT ACT CCG AAA
ATT ATG CGG ATG CGT CTT AAT G) and DAS-bot (59 -
GAT CCA TTA AGA CGC ATC CGC ATA ATT TTC GGA
GTA ATT TTC ATC GTT CGC AGC A), and ligated to SpeI/
BamHI digested plasmid pKAN [36]. As part of an unrelated
study, a fragment of the E. coli hisS gene was cloned into
pKAN(DAS) using SacI and SpeI sites. The resulting hisS-(DAS)
SacI/BamHI fragment was subcloned into plasmid pTrc99A
(Amersham Pharmacia) to generate plasmid pTrc(DAS). All cdiA-
CT/cdiI and rhs-CT/rhsI modules were subcloned into pTrc(DAS)
using NcoI and SpeI restriction sites. The sspB and sspB(D47)
genes were amplified using SspB-Nde (59 - GAG TTA ATC
CAT ATG GAT TTG TCA CAG C) in combination with
SspBD47-Bam (59 - TGC GGA TCC TTA ATT CAT GAT
GCT GGT ATG TTC ATC GTA GGC) and SspB-Bam (59 -
ATA TGA TTG CCA GGA TCC CGC TAT TTT ATT AAG
TC), respectively. Both PCR products were digested with NdeI
and BamHI and ligated to plasmid pCH410, allowing L-arabinose
control of SspB and SspB(D47) expression [37].
The orphan cdiA-CTo1
EC93/cdiIo1
EC93 module from E. coli EC93
was fused to the full-length EC93 cdiA
EC93 gene in multiple steps.
A fragment of cdiA
EC93 (upstream of the VENN encoding
sequence) was amplified using primers, #1527 (59 - GAA CAT
CCT GGC ATG AGC G) and #1758 (59 - CAA GCT CAG
CGA GTT ATT CTC AAC CGA GTT CCT ACC TGC CTG).
The EC93 orphan module was amplified using primers, #1759
(59 - CAG GCA GGT AGG AAC TCG GTT GAG AAT AAC
TCG CTG AGC TTG) and #1663 (59 - GGT CTG GTG TCT
AAC CTT TGG G). The two products were combined by
overlapping-end PCR using primers #1527 and #1663, and the
resulting product digested with SphI and AvrII and ligated to
plasmid pDAL660D1-39 [4].
In Vitro Characterization of Orphan Modules
All CdiA-CT/CdiI-His6 complexes were overproduced and
purified by Ni
2+-affinity chromatography as described [5].
Complexes were eluted from Ni
2+-nitrilotriacetic acid resin with
native elution buffer [20 mM sodium phosphate (pH 7.0) –10 mM
b-mercaptoethanol – 250 mM imidazole], followed by dialysis in
storage buffer [20 mM sodium phosphate (pH 7.0) – 150 mM
NaCl – 10 mM b-mercaptoethanol]. CdiA-CT and CdiI-His6
proteins were separated from one another by Ni
2+-affinity
chromatography with denaturing buffer [20 mM sodium phos-
phate (pH 7.0) – 10 mM b-mercaptoethanol – 6 M guanidine-
HCl]. Denatured proteins were refolded by dialysis into storage
buffer. All purified proteins were quantified by absorbance at















21. The specificity of CdiA-CT/CdiI-His6 bind-
ing interactions was determined by Ni
2+-affinity co-purification as
described [5]. The tRNase activity of isolated and refolded CdiA-
CT
UPEC536 and CdiA-CTo1
EC93 proteins was determined as
described [5,37].
In Vivo Activity of Orphan Modules
E. coli strain CH4180 (690 DsspB) was co-transformed with
pTrc(DAS) orphan module constructs and either the SspB or
SspB(D47) arabinose-inducible expression plasmids. The resulting
strains were grown at 37uC with aeration in LB media
supplemented with 150 mg/mL ampicillin and 10 mg/mL tetra-
cycline (to maintain plasmids) to mid-log phase and re-diluted into
fresh media to an optical density at 600 nm (OD600) of 0.05. After
40 min, SspB or SspB(D47) expression was induced by the
addition of 0.4% L-arabinose. Cell growth was tracked by
measuring the OD600 every 30 min after induction. Cells
expressing CdiA-CTo1
EC93/CdiIo1
EC93-DAS were harvested into
an equal volume of ice-cold methanol and RNA extracted as
described [38]. Northern blot hybridizations were conducted as
described [37], using radiolabeled oligonucleotides tRNA
His
probe (59 - CAC GAC AAC TGG AAT CAC) and tRNA1B
Ala
probe (59 - TCC TGC GTG AGC AG) as probes.
E. coli sspB




3937 were transformed with plasmids encoding rhs-CT/
rhsI(DAS) modules under control of the PBAD promoter [39].
Competent cells were incubated with 0.5 mg of purified super-
coiled plasmid for 20 min on ice, then heat-shocked at 42uC for
45 s. The treated cells were recovered in 1.0 mL of LB media for
2 hr without selection, then 20 mL of the cell suspension was
plated onto LB-agar supplemented with ampicillin (150 mg/mL),
tetracycline (10 mg/mL) and 0.4% L-arabinose. E. coli DsspB cells
were also transformed in the same manner with arabinose-
inducible rhs-CT/rhsI(DAS) constructs to confirm that growth
inhibition was dependent upon RhsI-DAS degradation.
EC93 cdiA-CT/cdiI Deletions
The main cdiA-CT
EC93 region and cdiI
EC93 gene were deleted
from rifampicin-resistant E. coli strain EC93 (DL3852) using allelic
exchange as described [4,40]. Sequence upstream of cdiA-CT
EC93
was amplified using oligonucleotides #1683 (59 - CAA CAA
GAG CTC GAA CAT CCT GGC ATG AGC G) and #1684 (59
- CAG CGA GTT ATT CTC AAC AAC AAC TA CGA GTT
CCT ACC TGC CTG) (SacI restriction endonuclease site is
underlined). Sequence downstream of cdiI
EC93 (including the
cdiI
EC93 stop codon) was amplified using oligonucleotides #1685
(59 - CAG GCA GGT AGG AAC TCG tag TTG TTG TTG
AGA ATA ACT CGC TG) and #1686 (59 - CAA CAA TCT
AGA CCC GAC TTT GAG ACC AGA ATA TC) (XbaI
restriction endonuclease site is underlined). The two PCR products
were combined by overlapping-end PCR using primers #1683
and #1686, and the resulting product digested with SacI and
XbaI and ligated to suicide vector pRE112 [40].
The orphan cdiA-CTo
EC93/cdiIo
EC93 module was deleted from
rifampicin-resistant EC93 in a similar manner. Sequence upstream
of cdiA-CTo1
EC93 was amplified using oligonucleotides #1714 (59 -
CAA CAA GAG CTC GTG AAG GTG GGC TTA CTC AG)
and #1715 (59 - CGA CTT TGA GAC CAG AAT ATC TAT
TTA CTC AAC AAC AAC TAT TTT CTG TCT AAG) (SacI
restriction endonuclease site is underlined). Sequence downstream
of cdiIo1
EC93 (including the cdiIo1
EC93 stop codon) was amplified
Toxin Effectors of CDI and Rhs Systems
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GTT GTT GTT GAG TAA ATA GAT ATT CTG GTC TCA
AAG TCG) and #1717 (59 - CAA CAA TCT AGA CCC GTA
AGT ATG CTT ATC CCA TG) (XbaI restriction endonuclease
site is underlined). The two PCR products were combined by
overlapping-end PCR using primers #1714 and #1717, and the
resulting product digested with SacI and XbaI and ligated to
suicide vector pRE112 [40].
Growth Competition Assays
E. coli strain EPI100 carrying plasmids pWEB-TNC (CDI
2),
pDAL660D1-39 (CdiA
EC93), or pDAL879 (CdiA
EC93-CTo1
EC93
chimera) were grown overnight at 37uC in LB media supplement-
ed 100 mg/mL of ampicillin. Overnight cultures were diluted into
fresh medium to OD600 of 0.05, and incubated at 37uC with
aeration until the culture reached mid-log phase (OD600<0.3).
The log-phase inhibitor cultures were then mixed with target E.
coli cells – CAG18439 pBR322 (no CdiI), pDAL741 (CdiI
EC93), or
pDAL867 (CdiIo1
EC93) – at an inhibitor to target cell ratio of 10:1.
The co-cultures were incubated for 2 hr at 37uC with aeration.
Viable target cell counts were determined by serially dilution of the
co-cultures into M9 salt solution followed by plating onto LB agar
supplemented with 10 mg/mL of tetracycline.
To assay CdiIo1 expression in EC93, growth competitions were
conducted with streptomycin-resistant EC93 (DL6104) carrying
pDAL879 (CdiA
EC93-CTo1
EC93 chimera) as the inhibitor strain.
Target strains were rifampicin-resistant EC93 carrying plasmid
pBR322 (no CdiI), and rifampicin-resistant EC93 DcdiA-CTo1
DcdiIo1 cells carrying pBR322 (no CdiI) or pDAL867 (CdiIo1
EC93).
Growth competitions were conducted as described above except
that mid-log phase cells were mixed and co-cultured at an
inhibitor to target ratio of 1:1. Viable target cell counts were
determined by serial dilution of the co-cultures into M9 salt
solution followed by plating onto LB agar supplemented with
150 mg/mL of rifampicin.
Quantitative RT-PCR Analysis






followed by treatment with RNase-free DNase I (Roche) to
remove contaminating chromosomal DNA. RNA (0.5 mg) was
reverse transcribed using the iScript cDNA synthesis kit (Bio-Rad).
A control without reverse transcriptase was also prepared to assess
chromosomal DNA contamination. Quantitative PCR was carried
out on a Bio-Rad MyiQ single-color real-time PCR detection
system using SYBR green supermix. The following primers sets
were used for amplification: #1700 (59 - GGT GAA GGT GGG
CTT ACT CA) and #1701 (59 - TGA TGT GAC AGA GCC
AAA GC) for cdiA-CT
EC93; #1698 (59 - TGC TAT GTA CTG
TAC TTG GTC) and #1699 (59 - TAA AGC CTA TGG GAT
TCC T) for cdiI
EC93; #1647 (59 - ACT GAC CGC TGA TGA
ACT GG) and #1648 (59 - AGT AGC CGC TTG AAC CTG
CAC) for cdiA-CTo1
EC93; #1649 (59 - TGA ACC CAA CAG
TCG CTC TTC) and #1650 (59 - GTC TTC CCC AGC CAG
AGG AT) for cdiIo1
EC93; #1568 (59 - TCA CCC CAG TCA
TGA ATC AC) and #1569 (59 - TGC AAC TCG ACT CCA
TGA AG) for 16S rRNA. Thermal cycling conditions were: 95uC
for 5 min for polymerase activation and collection of experimental
well factors and 40 cycles at 95uC for 10 s; 56uC for 30 s and 72uC
for 30s followed by a melting curve (55uCt o9 5 uC) to analyze the
end product. Data were analyzed using the iQ5 optical system
software (Bio-Rad) and exported to Microsoft Excel and Prism 5.0
for further analysis. For each target gene, a standard curve was
generated to assess PCR efficiency (E) allowing the expression level
(e) to be determined, where (e)=(Etarget)
2Ct target/(Eref)
2Ct ref [41].
Gene expression was normalized to a 16S rRNA RT-PCR
product amplified from the corresponding sample, and the
reported values represent the mean 6 SEM from three
independent RNA extractions.
Supporting Information
Figure S1 The EC93 orphan CdiA-CT/CdiI protein pair is
related to the CdiA-CT/CdiI proteins from E. coli UPEC 536.
A) Pairwise alignment of CdiA-CTo1
EC93 and CdiA-CT
UPEC536
shows 76% sequence identity. Numbering begins at the Val
residue of the conserved VENN motif. B) Alignment of CdiIo1
EC93
and CdiI
UPEC536 shows 35% sequence identity.
(TIF)
Figure S2 Orphan cdiA-CT fragments contain varying amounts
of cdiA sequence upstream of the region encoding VENN. A) The
region II cdi locus from Y. pseudotuberculosis PB1/+. CTo1 to CTo4
designate the orphan cdiA-CTo
PB1(II) genes numbered according to
their position in the locus. Dots above cdiA
PB1(II) represent every
500 amino acids of the encoded protein. B) Pairwise alignments of
the full-length Y. pseudotuberculosis PB1/+ region II cdiA gene with
the linked orphan cdiA-CT sequences. The region where similarity
with the full-length cdiA
PB1(II) gene begins is shown for each orphan
cdiA-CT sequence. Gray shading indicates nucleotide identity, and
the numbers correspond to amino acid residues of the full-length
CdiA
PB1(II) protein. Amino acid sequences are given in one-letter
code and asterisks (*) indicate termination codons. C) The
nucleotide and predicted amino acid sequences for the VENN-
encoding regions are presented. Orphan sequences shaded in gray
are identical to that of the full-length cdiA
PB1(II) gene.
(TIF)
Figure S3 Multiple sequence alignment of Y. pseudotuberculosis
PB1/+ cdiA-CT nucleotide sequences. The nucleotide sequences
encoding orphan cdiA-CTs from the Y. pseudotuberculosis PB1/+
region II cdi locus were aligned to the full-length cdiA
PB1(II) gene.
Numbering corresponds to the full-length CdiA
PB1(II) protein
sequence. Black indicates positions of sequence identity with the
full cdiA
PB1(II) gene. Sequence identity falls off abruptly after the
VENN-encoding region (grey).
(PDF)
Figure S4 VENN-encoding sequences demarcate orphan cdiA-
CT fragments. The orphan cdiA-CTo1 of E. coli 254 is related to
orphan cdiA-CTo7 of E. coli EC869. The conserved region is shaded
gray, and the left and right junctions of the conserved region are
presented in detail. Conservation begins at the VENN-encoding
regions for cdiA-CTo1
254 and cdiA-CTo7
EC869 (left junction) and
extends through the predicted orphan cdiI genes to the VENN
encoding regions of the following orphan cdiA-CT genes (99%
sequence identity in 1048 nucleotides). The sequences then





Figure S5 The CdiAI-CT of Y. pestis Microtus 91001 is
unrelated to CdiA-CTs from other Y. pestis strains. Pairwise
alignment of CdiA
(I) proteins encoded by the region I cdi loci of Y.
pestis Microtus 91001 and Y. pestis CO92. Numbers correspond to
amino acid residues of the full-length predicted CdiA
(I) proteins.
Regions of sequence identity are shaded gray and the VENN
peptide motif is boxed.
(TIF)
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and E. coli EC869 encode functional toxin/immunity pairs. A)






His6 complexes were purified by Ni
2+-affinity chromatography
under non-denaturing conditions and analyzed by SDS-PAGE. B)
Growth curves of E. coli DsspB cells expressing orphan CdiA-CT/
CdiI-DAS complexes. Degradation of CdiI-DAS proteins was
initiated by the addition of L-arabinose to induce SspB synthesis.
Control cells express SspB(D47), which does not deliver CdiI-DAS
proteins to the ClpXP protease. Growth curves with square
symbols represent control strains expressing SspB or SspB(D47),
but not orphan CdiA-CT/CdiI-DAS complexes.
(TIF)
Figure S7 The CdiAI-CT of Y. pestis Microtus 91001 is related to
an Rhs-CT from Waddlia chondrophila. Pairwise alignment of
Y. pestis Microtus CdiA-CT
91001(I) (Q74T84) and the C-terminal
region of a predicted Rhs/YD-repeat protein from Waddlia
chondrophila WSU 86–1044 (D6YTT8). Regions of sequence
identity are shaded gray and the PxxxxDPxGL and VENN
peptide motifs are boxed.
(TIF)
Figure S8 The C-terminal regions of Rhs proteins are variable.
Pairwise alignment of related Rhs proteins from Y. pseudotuberculosis
IP31758 and Y. pseudotuberculosis IP32953. Regions of identity are
shaded gray. Sequences diverge abruptly after the DPxGL motif
(boxed).
(TIF)
Table S1 Homologies between selected CdiA-CT and Rhs-CT
sequences. Rhs-CT sequences were identified by BLAST searches
using selected CdiA-CTs as the query sequences. The presence of
probable rhs-CT/rhsI orphan modules is indicated for each Rhs
system.
(XLS)
Table S2 Sequence identifiers for CdiA and Rhs proteins. The
UniProt, GenBank and locus tag accession numbers are presented
for each CdiA and Rhs protein discussed in the text.
(XLS)
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